Key result
Wireless intravascular blood-pressure sensor tracks stable pressure for 6 months, but femoral stress causes failures.
Why the study?
Long-term monitoring of malignant hypertension is important to guide treatment and prevent secondary consequences, yet current devices are not suited for long-term blood-pressure measurement.
Answers are grounded in this paper and cite their sources.
Long-term in-vivo testing supports device feasibility; leaves open safety, accuracy, and outcome data before hypertension use.
Introduction Long-term monitoring of malign hypertension patients is important for physicians to prescribe appropriate medical treatment in order to reduce the incidence of secondary consequences such as stroke, kidney failure or heart insufficiency. However, current devices are not suited for long-term blood-pressure measurement. In order to address this need, we developed and conducted in-vivo tests on a novel, fully-implantable, wireless blood-pressure monitoring system. Methods The monitoring system was tested for six months in 12 chronic ovine models. The sensor was implanted with X-raycontrol in the femoral artery by means of a dedicated sheath (PASIS). Reference measurements were recorded with industry standard pressure sensors post implantation. Position and proper functioning of the sensor were controlled via regular readout measurements and CTs. At the end of each trial, a histological examination was conducted. Results Chronic in-vivo studies revealed that blood pressure measurement over a period of six months was possible with the novel implantable sensor system. Stable pressure histories were recorded. However, the mechanical resilience of the sensor system requires improvement. The in-vivo tests in the femoral artery of sheep produced high stress on the sensors system. Several implanted systems became inoperative despite efforts to stiffen the sensor-cable. The histological analysis detected no thrombi, however mild ingrowth was observed in several cases. Conclusion The results of the chronic in-vivo tests on the novel implantable blood-pressure monitoring system were encouraging. Improvements need to be made regarding the mechanical resilience of the system and the coating needs to investigated to reduce ingrowth-behavior. Additional trials at a modified implantation spot will be conducted in order to reveal further insights regarding system performance.
No takes yet. Share an insight, caveat, or question.
Cleven et al. (2012) studied Malign hypertension (preclinical ovine model) (n=12). Fully-implantable, wireless intravascular blood-pressure monitoring system vs. Industry standard pressure sensors (post-implantation reference) was evaluated on Feasibility of long-term blood pressure measurement, mechanical resilience, and histological tissue response (thrombi and ingrowth). The wireless intravascular blood-pressure sensor recorded stable pressure for 6 months in 12 sheep without thrombi, though high femoral stress caused several device failures.
Synapse has enriched 10 related papers. Consider them for comparative context: